Jin Hong-Jian, Kim Jung, Yu Jindan
Division of Hematology/Oncology, Department of Medicine, Chicago, IL 60611, USA.
Division of Hematology/Oncology, Department of Medicine, Chicago, IL 60611, USA ; Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
Transl Androl Urol. 2013 Sep;2(3):157-177. doi: 10.3978/j.issn.2223-4683.2013.09.01.
The transcriptional activity of the androgen receptor (AR) is not only critical for the normal development and function of the prostate but also pivotal to the onset and progression of prostate cancer (PCa). The studies of AR transcriptional regulation were previously limited to a handful of AR-target genes. Owing to the development of various high-throughput genomic technologies, significant advances have been made in recent years. Here we discuss the discoveries of genome-wide androgen-regulated genes in PCa cell lines, animal models and tissues using expression microarray and sequencing, the mapping of genomic landscapes of AR using Combining Chromatin Immunoprecipitation (ChIP)-on-chip and ChIP-seq assays, the interplay of transcriptional cofactors in defining AR binding profiles, and the genomic regulation and AR reprogramming in advanced PCa.
雄激素受体(AR)的转录活性不仅对前列腺的正常发育和功能至关重要,而且对前列腺癌(PCa)的发生和发展也起着关键作用。以往对AR转录调控的研究仅限于少数AR靶基因。由于各种高通量基因组技术的发展,近年来取得了重大进展。在此,我们讨论了利用表达微阵列和测序技术在PCa细胞系、动物模型和组织中全基因组雄激素调控基因的发现,利用芯片结合染色质免疫沉淀(ChIP)和ChIP-seq分析对AR基因组景观的绘制,转录辅因子在定义AR结合谱中的相互作用,以及晚期PCa中的基因组调控和AR重编程。